FEV1 shows how much air leaves the lungs during the first second, whereas forced vital capacity represents the total volume expelled during the maneuver. Comparing these measurements helps clinicians assess whether airflow is limited during forced exhalation. This combined interpretation is more informative for evaluating pulmonary function than considering the first-second volume in isolation.
Airway inflammation can be associated with bronchial obstruction and respiratory impairment, which may reduce the volume expelled during forced exhalation. In immunology and infection research, changes in FEV measurements therefore provide a functional indicator of how airway disease affects breathing. The measurements help connect inflammatory or infectious processes with measurable pulmonary consequences.
FEV1 focuses on the speed of exhalation during its first second, while the total forced vital capacity reflects the complete volume exhaled during the maneuver. A person may therefore have information about both early airflow and overall expelled volume. Examining these complementary values helps characterize airflow limitation and respiratory impairment more precisely.
The individual first inhales fully to establish a maximal starting breath. They then exhale as rapidly and completely as possible while the spirometry recording captures the expelled volume over defined time intervals. This procedure produces measurements such as FEV1 and forced vital capacity, allowing the resulting pattern to be evaluated for pulmonary function.
FEV measurements provide a way to evaluate airway inflammation, bronchial obstruction, and respiratory impairment associated with asthma or pulmonary infection. Investigators can use the recorded values to characterize how these conditions affect lung function. Because the measurements can be collected over time, they also support assessment of disease progression and response to treatment.
Changes in FEV values can help track whether respiratory impairment is progressing, remaining stable, or changing during treatment. In infection and immunology studies, this longitudinal information links pulmonary function with the course of airway disease. Researchers and clinicians can compare measurements across assessments to evaluate treatment response in conditions such as asthma or pulmonary infection.